{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:50:08Z","timestamp":1787961008462,"version":"build-2784847793"},"reference-count":90,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Wilson\u2019s disease (WD) is a rare autosomal recessive (AR) disorder resulting from mutations in the ATP7B gene, which is responsible for the encryption of transmembrane copper transporting ATPase. The symptomatic presentation of the disease is estimated to be about 1 in 30,000. The impairment of ATP7B function results in a copper overload in hepatocytes, which further leads to liver pathology. This copper overload also occurs in other organs, most particularly in the brain. This could then cause the occurrence of neurological and psychiatric disorders. Symptoms differ substantially and most often occur between the ages of 5 and 35 years. Early symptoms are commonly hepatic, neurological, or psychiatric. While disease presentation is most often asymptomatic, it could also range as far as to include fulminant hepatic failure, ataxia, and cognitive disorders. Various treatments are available for Wilson\u2019s disease, including chelation therapy and zinc salts, which can reverse copper overload through different mechanisms. In select cases, liver transplantation is recommended. New medications, such as tetrathiomolybdate salts, are currently being investigated in clinical trials. With prompt diagnosis and treatment, prognosis is favorable; however, diagnosing patients before the onset of severe symptoms is a significant concern. Early screening for WD could help in diagnosing patients earlier and improving treatment outcomes.<\/jats:p>","DOI":"10.3390\/diagnostics13050893","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T04:13:16Z","timestamp":1677471196000},"page":"893","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neurological Wilson\u2019s Disease Signs\u2014Hepatic Encephalopathy or Copper Toxicosis?"],"prefix":"10.3390","volume":"13","author":[{"given":"Anna","family":"Jopowicz","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation, Sparta\u0144ska 1, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Tarnacka","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Faculty of Medicine, Warsaw Medical University, Sparta\u0144ska 1, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Nature Reviews Disease Primers Article: Wilson Disease","volume":"4","author":"Litwin","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.21037\/atm.2019.04.27","article-title":"Clinical Presentations of Wilson Disease","volume":"7","author":"Shribman","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05109.x","article-title":"Neurologic Wilson\u2019s Disease","volume":"1184","author":"Lorincz","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson\u2019s Disease and Other Neurological Copper Disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101768","DOI":"10.1016\/j.bpg.2021.101768","article-title":"Wilson\u2019s Disease-Management and Long Term Outcomes","volume":"56\u201357","author":"Socha","year":"2022","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/archdischild-2018-315705","article-title":"Wilson Disease in Children and Adolescents","volume":"105","author":"Fernando","year":"2020","journal-title":"Arch. Dis. Child."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ncl.2014.09.006","article-title":"Wilson Disease and Other Neurodegenerations with Metal Accumulations","volume":"33","author":"Dusek","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/atm-21-2264","article-title":"Wilson Disease and the Differential Diagnosis of Its Hepatic Manifestations: A Narrative Review of Clinical, Laboratory, and Liver Histological Features","volume":"9","author":"Schroeder","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ncl.2020.01.005","article-title":"Wilson Disease: An Overview and Approach to Management","volume":"38","author":"Mulligan","year":"2020","journal-title":"Neurol. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4254\/wjh.v13.i6.634","article-title":"Wilson\u2019s Disease: Revisiting an Old Friend","volume":"13","author":"Ampuero","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_11","first-page":"74","article-title":"Wilson\u2019s Disease Masquerading as Nonalcoholic Steatohepatitis","volume":"1","author":"Mahmood","year":"2009","journal-title":"N. Am. J. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/liv.13752","article-title":"Hepatic Encephalopathy: Diagnosis and Management","volume":"38","author":"Amodio","year":"2018","journal-title":"Liver Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jceh.2014.09.002","article-title":"Encephalopathy in Wilson Disease: Copper Toxicity or Liver Failure?","volume":"5","author":"Ferenci","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1478-3231.2009.02089.x","article-title":"Night-Time Sleep Disturbance Does Not Correlate with Neuropsychiatric Impairment in Patients with Cirrhosis","volume":"29","author":"Montagnese","year":"2009","journal-title":"Liver Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1572-0241.2001.03552.x","article-title":"Focal Neurological Signs in Hepatic Encephalopathy in Cirrhotic Patients: An Underestimated Entity?","volume":"96","author":"Cadranel","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/978-1-60327-426-5_28","article-title":"Wilson\u2019s Disease with Wing-Beating Tremor","volume":"36","author":"Bhidayasiri","year":"2012","journal-title":"Curr. Clin. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/01.aids.0000192076.03443.6d","article-title":"Neurological and Neuropsychiatric Syndromes Associated with Liver Disease","volume":"19","author":"Weissenborn","year":"2005","journal-title":"AIDS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40265-018-1018-z","article-title":"Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles","volume":"79","author":"Weissenborn","year":"2019","journal-title":"Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jhep.2012.11.043","article-title":"Cirrhosis-Related Parkinsonism: Prevalence, Mechanisms and Response to Treatments","volume":"58","author":"Tryc","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jhep.2011.12.014","article-title":"The Impact of Organ Dysfunction in Cirrhosis: Survival at a Cost?","volume":"56","author":"Shawcross","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The Animal Naming Test: An Easy Tool for the Assessment of Hepatic Encephalopathy","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.12968\/bjon.2018.27.Sup3.S7","article-title":"Diagnosis and Management of Hepatic Encephalopathy","volume":"27","author":"Shawcross","year":"2018","journal-title":"Br. J. Nurs."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jceh.2018.08.009","article-title":"Wilson\u2019s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India","volume":"9","author":"Nagral","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/B978-0-444-63625-6.00014-8","article-title":"Diagnosis of Wilson Disease","volume":"142","author":"Ferenci","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2011.08.028","article-title":"Gender Differences in Wilson\u2019s Disease","volume":"312","author":"Litwin","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.disamonth.2014.07.003","article-title":"Wilson\u2019s Disease: Neurological and Psychiatric Manifestations","volume":"60","author":"Dalvi","year":"2014","journal-title":"Disease-a-Month"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/mds.1118","article-title":"Dystonia in Wilson\u2019s Disease","volume":"16","author":"Svetel","year":"2001","journal-title":"Mov. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-017-0921-3","article-title":"Comparative Assessment of Clinical Rating Scales in Wilson\u2019s Disease","volume":"17","author":"Volpert","year":"2017","journal-title":"BMC Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mds.21761","article-title":"Evaluation of the Unified Wilson\u2019s Disease Rating Scale (UWDRS) in German Patients with Treated Wilson\u2019s Disease","volume":"23","author":"Leinweber","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2045125318759461","article-title":"Psychiatric Manifestations in Wilson\u2019s Disease: Possibilities and Difficulties for Treatment","volume":"8","author":"Litwin","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.parkreldis.2009.01.010","article-title":"Neuropsychiatric Aspects of Treated Wilson\u2019s Disease","volume":"15","author":"Svetel","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2007.09.009","article-title":"Dominant Psychiatric Manifestations in Wilson\u2019s Disease: A Diagnostic and Therapeutic Challenge!","volume":"266","author":"Srinivas","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.genhosppsych.2013.08.007","article-title":"Psychiatric Aspects of Wilson Disease: A Review","volume":"36","author":"Zimbrean","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-12-52","article-title":"Bipolar Disorders and Wilson\u2019s Disease","volume":"12","author":"Carta","year":"2012","journal-title":"BMC Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-444-63625-6.00011-2","article-title":"Cognitive and Psychiatric Symptoms in Wilson Disease","volume":"142","author":"Zimbrean","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1745017901208010102","article-title":"Quality of Life and Psychiatric Symptoms in Wilson\u2019s Disease: The Relevance of Bipolar Disorders","volume":"8","author":"Carta","year":"2012","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.10195","article-title":"Cognitive Functioning in Neurologically Symptomatic and Asymptomatic Forms of Wilson\u2019s Disease","volume":"17","author":"Bak","year":"2002","journal-title":"Mov. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S1980-57642009DN30100004","article-title":"Cognitive Impairment in Wilson\u2019s Disease","volume":"3","author":"Frota","year":"2009","journal-title":"Dement. Neuropsychol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/neu0000103","article-title":"Diverse Attention Deficits in Patients with Neurologically Symptomatic and Asymptomatic Wilson\u2019s Disease","volume":"29","author":"Litwin","year":"2015","journal-title":"Neuropsychology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.parkreldis.2022.01.016","article-title":"Prevalence and Features of Non-Motor Symptoms in Wilson\u2019s Disease","volume":"95","author":"Palmieri","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mds.22231","article-title":"A Novel Global Assessment Scale for Wilson\u2019s Disease (GAS for WD)","volume":"24","author":"Aggarwal","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08039480260242796","article-title":"Sleep in Patients with Treated Wilson\u2019s Disease. A Questionnaire Study","volume":"56","author":"Portala","year":"2002","journal-title":"Nord. J. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1468-1331.2010.03106.x","article-title":"Sleep Disorders in Wilson\u2019s Disease","volume":"18","author":"Nevsimalova","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"ref_45","first-page":"184","article-title":"Sleep Disorders in Wilson\u2019s Disease","volume":"19","author":"Woimant","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ane.12585","article-title":"Restless Legs Syndrome in Wilson\u2019s Disease: Frequency, Characteristics, and Mimics","volume":"135","author":"Trindade","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1176\/appi.neuropsych.13120362","article-title":"Catatonia: An Unusual Manifestation of Wilson\u2019s Disease","volume":"27","author":"Basu","year":"2015","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4103\/0019-5359.37047","article-title":"Wilson\u2019s Disease Presenting as Isolated Obsessive-Compulsive Disorder","volume":"61","author":"Kumawat","year":"2007","journal-title":"Indian J. Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0016-5085(97)70097-0","article-title":"Wilson\u2019s Disease in Patients Presenting with Liver Disease: A Diagnostic Challenge","volume":"113","author":"Steindl","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2009.06.022","article-title":"Serum Ceruloplasmin Oxidase Activity Is a Sensitive and Highly Specific Diagnostic Marker for Wilson\u2019s Disease","volume":"51","author":"Merle","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/qjmed\/hct137","article-title":"The Acute Haemolytic Syndrome in Wilson\u2019s Disease\u2014A Review of 22 Patients","volume":"106","author":"Walshe","year":"2013","journal-title":"QJM Int. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jhep.2007.03.011","article-title":"Re-Evaluation of the Penicillamine Challenge Test in the Diagnosis of Wilson\u2019s Disease in Children","volume":"47","author":"Koppikar","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MPG.0000000000001787","article-title":"Wilson\u2019s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition","volume":"66","author":"Socha","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2007.05.002","article-title":"Non-Invasive Testing for Wilson Disease: Revisiting the d-Penicillamine Challenge Test","volume":"47","author":"Schilsky","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0950-3528(98)90133-6","article-title":"Wilson Disease","volume":"12","author":"Roberts","year":"1998","journal-title":"Baillieres. Clin. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1542-3565(05)00484-2","article-title":"Wilson\u2019s Disease","volume":"3","author":"Ferenci","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/hep.23910","article-title":"Re-Evaluation of the Diagnostic Criteria for Wilson Disease in Children with Mild Liver Disease","volume":"52","author":"Nicastro","year":"2010","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrneurol.2017.128","article-title":"Long-Term Effects of Exercise and Physical Therapy in People with Parkinson Disease","volume":"13","author":"Mak","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00535-020-01752-1","article-title":"Diagnosis for Wilson Disease: This Disease May Not Be a Rare Disease","volume":"56","author":"Harada","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/liv.13715","article-title":"Accuracy of the Radioactive Copper Incorporation Test in the Diagnosis of Wilson Disease","volume":"38","author":"Rodo","year":"2018","journal-title":"Liver Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","article-title":"Diagnosis and Phenotypic Classification of Wilson Disease","volume":"23","author":"Ferenci","year":"2003","journal-title":"Liver Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/qjmed\/hcr229","article-title":"Serum \u201cfree\u201d Copper in Wilson Disease","volume":"105","author":"Walshe","year":"2012","journal-title":"QJM Int. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840150410","article-title":"Value of Urinary Copper Excretion after Penicillamine Challenge in the Diagnosis of Wilson\u2019s Disease","volume":"15","author":"Baldwin","year":"1992","journal-title":"Hepatology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000198559","article-title":"Urinary Copper Excretion and Hepatic Copper Concentrations in Liver Disease","volume":"21","author":"Frommer","year":"1981","journal-title":"Digestion"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jimd.12046","article-title":"Long-Term Evaluation of Urinary Copper Excretion and Non-Caeruloplasmin Associated Copper in Wilson Disease Patients under Medical Treatment","volume":"42","author":"Pfeiffenberger","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jocn.2018.10.096","article-title":"A Study of Brain MRI Characteristics and Clinical Features in 76 Cases of Wilson\u2019s Disease","volume":"59","author":"Zhong","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3174\/ajnr.A5936","article-title":"MR Imaging of the Brain in Neurologic Wilson Disease","volume":"40","author":"Yu","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR Chemical Shifts and Coupling Constants for Brain Metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroimage.2010.04.260","article-title":"Brain Edema Dynamics in Patients with Overt Hepatic Encephalopathy. A Magnetic Resonance Imaging Study","volume":"52","author":"Poveda","year":"2010","journal-title":"Neuroimage"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jceh.2013.10.001","article-title":"Magnetic Resonance Imaging and Spectroscopy in Hepatic Encephalopathy","volume":"5","author":"Chavarria","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2019.07.008","article-title":"Magnetic Resonance Spectroscopy: A Surrogate Marker of Hepatic Encephalopathy?","volume":"71","author":"Hermann","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.parkreldis.2009.02.007","article-title":"Metabolic Changes in 37 Newly Diagnosed Wilson\u2019s Disease Patients Assessed by Magnetic Resonance Spectroscopy","volume":"15","author":"Tarnacka","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/mds.22163","article-title":"MR Spectroscopy in Monitoring the Treatment of Wilson\u2019s Disease Patients","volume":"23","author":"Tarnacka","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zhang, L.J., Qi, R., Zhong, J., Xu, Q., Zheng, G., and Lu, G.M. (2012). The Effect of Hepatic Encephalopathy, Hepatic Failure, and Portosystemic Shunt on Brain Volume of Cirrhotic Patients: A Voxel-Based Morphometry Study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042824"},{"key":"ref_75","first-page":"2149","article-title":"MR and 1H MR Spectroscopy of the Brain in Patients with Liver Cirrhosis and Early Stages of Hepatic Encephalopathy","volume":"50","author":"Panasiuk","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"ref_76","first-page":"1","article-title":"Advances in Treatment of Wilson Disease","volume":"8","author":"Aggarwal","year":"2018","journal-title":"Tremor Other Hyperkinet. Mov."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Peng, A.J., Chen, L., Li, Y., Fang, J.J., Zhou, D., and Feng, P. (2017). Penicillamine for Wilson\u2019s Disease. Cochrane Database Syst. Rev., 2017.","DOI":"10.1002\/14651858.CD009739.pub2"},{"key":"ref_78","unstructured":"(2023, January 12). Nice. The NICE Medicines and Technologies Programme on behalf of NHS England Specialised Commissioning Key Points from the Evidence. Available online: https:\/\/www.nice.org.uk\/Media\/Default\/About\/NICE-Communities\/Medicines-prescribing\/ER-NHSE-trientine-wilsons-disease.pdf."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Coni, P., Pichiri, G., Lachowicz, J.I., Ravarino, A., Ledda, F., Fanni, D., Gerosa, C., Piras, M., Coghe, F., and Gibo, Y. (2021). Zinc as a Drug for Wilson\u2019s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules, 26.","DOI":"10.3390\/molecules26216614"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Avan, A., Cz\u0142onkowska, A., Gaskin, S., Granzotto, A., Sensi, S.L., and Hoogenraad, T.U. (2022). The Role of Zinc in the Treatment of Wilson\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169316"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40846-015-0087-7","article-title":"Combination Therapy Using Chelating Agent and Zinc for Wilson\u2019s Disease","volume":"35","author":"Chen","year":"2015","journal-title":"J. Med. Biol. Eng."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1756283X17731520","article-title":"Insights into the Management of Wilson\u2019s Disease","volume":"10","author":"Kathawala","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MPG.0000000000000926","article-title":"Zinc Therapy for Wilson Disease in Children in French Pediatric Centers","volume":"61","author":"Santiago","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_84","first-page":"465","article-title":"Management Perspective of Wilson\u2019s Disease: Early Diagnosis and Individualized Therapy","volume":"19","author":"Yuan","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","article-title":"Treatment of Wilson Disease with Ammonium Tetrathiomolybdate: IV. Comparison of Tetrathiomolybdate and Trientine in a Double-Blind Study of Treatment of the Neurologic Presentation of Wilson Disease","volume":"63","author":"Brewer","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.parkreldis.2019.02.016","article-title":"Wilson\u2019s Disease: A Master of Disguise","volume":"59","author":"Hedera","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/14737175.2019.1645009","article-title":"A Review and Update on the Diagnosis and Treatment of Neuropsychiatric Wilson Disease","volume":"19","author":"Cleymaet","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/sjg.sjg_501_21","article-title":"Wilson Disease in Children and Young Adults\u2014State of the Art","volume":"28","author":"Chanpong","year":"2022","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2468-1253(17)30293-5","article-title":"Bis-Choline Tetrathiomolybdate in Patients with Wilson\u2019s Disease: An Open-Label, Multicentre, Phase 2 Study","volume":"2","author":"Weiss","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2018.12.013","article-title":"Brain Magnetic Resonance Spectroscopy (MRS) as a Diagnostic Tool for Detecting Early Neurological Changes in Children with Wilson\u2019s Disease","volume":"111","author":"Refaat","year":"2019","journal-title":"Eur. J. Radiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/5\/893\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:43:27Z","timestamp":1760121807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/5\/893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":90,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["diagnostics13050893"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13050893","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}